Breaking down barriers: new study seeks to improve prostate cancer genetic services for all
NCT ID NCT07407686
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand why some communities, including Black men, transgender individuals, and those with limited healthcare access, are less likely to use prostate cancer genetics services. Researchers will interview about 100 people to identify barriers and then work with community members to create easy-to-understand digital resources. The goal is to improve awareness and participation in genetic testing and screening.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better educational materials that help underserved communities understand and access prostate cancer genetic testing and screening.
What could go wrong
This is an early-stage, small study (100 participants) focused on gathering opinions and developing resources, not testing a treatment. The resources may not work as hoped in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••